In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice

  • Samalidou, M. Bougiouklis, D. Vyzantiadis, T.-A. Meletiadis, J. Monokrousos, N. Siotou, E. Sivropoulou, A. Anagnostopoulos, A. Sotiropoulos, D.
Publication date
January 2015

Abstract

Liposomal amphotericin B, voriconazole, and caspofungin are currently used for systemic and severe fungal infections. Patients with malignant diseases are treated with granulocyte-colony stimulating factor (G-CSF) for the recovery of granulocytes after chemotherapy or hematopoietic cell (HC) transplantation. Since they have a high incidence of fungal infections, they inevitably receive antifungal drugs for treatment and prophylaxis. Despite their proven less toxicity for various cell types comparatively with amphotericin B and the decrease in the number of leukocytes that has been reported as a possible complication in clinical studies, the effect of liposomal amphotericin B, voriconazole, and caspofungin on HCs has not been clarified. The ...

Extracted data

We use cookies to provide a better user experience.